Skip to content

Long-term Follow-up in Patients Affected With Acrofacial Vitiligo

Long-term Ten Years Follow-up in Patients Affected With Acrofacial Vitiligo

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01459055
Enrollment
100
Registered
2011-10-25
Start date
2016-05-31
Completion date
2020-08-31
Last updated
2016-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitiligo

Brief summary

Acrofacial vitiligo is a clinical form of vitiligo characterized by macules in distal digits, periorificial-facial and ano-genital areas. Vitiligo European Task Force classifies vitiligo as generalized or localized; generalized vitiligo may be further sub-divided into acrofacial, vulgaris and universalis, and localized vitiligo, into segmental and focal. Some authors do not believe that acrofacial is a real vitiligo clinical form, considering it as an initial form of vulgaris vitiligo. The aim of this study is to follow early- diagnosed acrofacial patients during ten years in order to define if these patients will maintain this clinical form or will evolute to a more severe clinical form.

Interventions

None listed

Sponsors

Irmandade da Santa Casa de Misericordia de Curitiba
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patients of both genders, aged older than years, able to understand and provide written informed consent and able to allow compliance at the treatment and the requirements of the protocol; 2. Presence of acrofacial vitiligo; 3. Able to comprehend and willing to provide written informed consent in accordance with institutional and regulatory guidelines.

Exclusion criteria

1- Subjects assessed as not suitable for the study in the opinion of the investigator 2 -Inability to complete survey

Countries

Brazil

Contacts

Primary ContactCaio Cesar C Castro, MD, PhD
caio.castro@pucpr.br00554135682036

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026